Abstract:BACKGROUND: Cardiac CD206+ macrophages expand acutely after myocardial infarction (MI) to promote wound healing; however, their role in chronic heart failure (HF) is unknown. We tested the hypothesis that cardiac CD206+ macrophages expressing interleukin(IL)-4Ralpha are key drivers of adverse left ventricular (LV) remodeling in HF. METHODS AND RESULTS: Adult male C57BL/6 mice underwent non-reperfused MI to induce HF, or sham operation, and cardiac macrophages were profiled using flow cytometry. As compared to sham, CD206+ macrophages steadily expanded in post-MI hearts during LV remodeling, such that at 8 w post-MI they comprised ~85% of all macrophages. These macrophages were robustly proliferative and predominantly C-C motif chemokine receptor (CCR2)− and major histocompatibility complex (MHC)IIhi, with >90% of CD206+CCR2− macrophages expressing the resident macrophage marker LYVE-1. CD206+ macrophage abundance correlated with LV dysfunction and fibrosis. Nearly half of CD206+ macrophages expressed IL-4Ralpha, and the majority of CD206+IL-4Ralpha+ macrophages co-expressed the pro-fibrotic protein found in inflammatory zone (FIZZ)1. IL-4-polarized bone marrow derived CD206+ macrophages also exhibited marked upregulation of FIZZ1 and induced FIZZ1-dependent myofibroblast differentiation of cardiac mesenchymal stem cells (cMSCs), in part related to DLL-4/Jagged1-Notch1 signaling. Intramyocardial adoptive transfer of M[IL-4], but not M[IL-10], CD206+ macrophages to naive mice, induced progressive LV remodeling over 4 weeks, increasing fibrosis, cardiomyocyte hypertrophy, and apoptosis. Myeloid-specific IL-4Ralpha gene deletion in established HF (initiated 4 w post-MI) in IL-4Ralphaf/fLysM-CreERT2 mice significantly reduced CD206+ macrophage proliferation and effectively depleted CD206+IL-4Ralpha+ cardiac macrophages. This was associated with abrogation of LV remodeling progression, reduction of cardiac fibrosis, and improved neovascularization. In vivo IL-4Ralpha gene silencing in mice with established HF effectively depleted cardiac CD206+IL-4Ralpha+ macrophages and reversed LV remodeling, improving fibrosis, neovascularization, and dysfunction, and suppressed both local and systemic inflammation. Lastly, alternatively activated CD206+ and CD163+ macrophages were significantly expanded in human failing hearts and correlated with fibrosis. The majority of CD163+ macrophages expressed IL-4Ralpha and FIZZ3, the human homolog of FIZZ1. CONCLUSION: Cardiac CD206+IL-4Ralpha+ macrophages proliferate and expand in HF and are key mediators of pathological remodeling and fibrosis, in part through the secretion of FIZZ1. Inhibition of CD206+ macrophage IL-4Ralpha signaling alleviates LV remodeling in ischemic cardiomyopathy.

Inhibition of Fibroblast IL-6 Production by ACKR4 Deletion Alleviates Cardiac Remodeling after Myocardial Infarction

CXCR6 deficiency ameliorated myocardial ischemia/reperfusion injury by inhibiting infiltration of monocytes and IFN-γ-dependent autophagy.

NKRF in Cardiac Fibroblasts Protects against Cardiac Remodeling Post‐Myocardial Infarction via Human Antigen R

Haplodeficiency of Activin Receptor-Like Kinase 4 Alleviates Myocardial Infarction-Induced Cardiac Fibrosis and Preserves Cardiac Function

Targeted inhibition of Focal Adhesion Kinase Attenuates Cardiac Fibrosis and Preserves Heart Function in Adverse Cardiac Remodeling

CD206+IL-4Ralpha+ MACROPHAGES ARE DRIVERS OF ADVERSE CARDIAC REMODELING IN ISCHEMIC CARDIOMYOPATHY

Myeloid Interleukin-4 Receptor Α is Essential in Postmyocardial Infarction Healing by Regulating Inflammation and Fibrotic Remodeling.

Myofibroblast Ccn3 is Regulated by Yap and Wwtr1 and Contributes to Adverse Cardiac Outcomes

Fibroblast-derived interleukin-6 exacerbates adverse cardiac remodeling after myocardial infarction

IL‑6 Inhibitors Effectively Reverse Post‑infarction Cardiac Injury and Ischemic Myocardial Remodeling Via the TGF‑β1/Smad3 Signaling Pathway

KIAA1199/CEMIP knockdown attenuates cardiac remodeling post myocardial infarction by activating TSP4 pathway in mice

The Impairment of ILK Related Angiogenesis Involved in Cardiac Maladaptation after Infarction.

Tissue kallikrein-related peptidase8 accentuates cardiac fibrosis after myocardial ischemia-reperfusion injury via regulation of cardiac fibroblasts

Loss Of?7nachr Enhances Endothelial-to-mesenchymal Transition after Myocardial Infarction Via NF-KB Activation

Pharmacological Inhibition of Focal Adhesion Kinase Attenuates Cardiac Fibrosis in Mice Cardiac Fibroblast and Post-Myocardial-Infarction Models

MicroRNAs Involved in the Regulation of Postischemic Cardiac Fibrosis

Interleukin-34-NF-κB signaling aggravates myocardial ischemic/reperfusion injury by facilitating macrophage recruitment and polarization

Targeting interleukin-21 inhibits stress overload-induced cardiac remodelling via the TIMP4/MMP9 signalling pathway

Retraction Note to: Amphiregulin enhances cardiac fibrosis and aggravates cardiac dysfunction in mice with experimental myocardial infarction partly through activating EGFR‑dependent pathway

Blockade of the Notch Signaling Pathway Promotes M2 Macrophage Polarization to Suppress Cardiac Fibrosis Remodeling in Mice With Myocardial Infarction

Interleukin-5 alleviates cardiac remodelling via the STAT3 pathway in angiotensin II-infused mice